EP3795170

PHARMACEUTICAL COMPOSITION COMPRISING CCN5 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING RETINAL DISEASES

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    16.5.2019
  • :
    20.3.2024
  • :
    19802765.8
  • :
    15.5.2039
  • :
    PHARMACEUTICAL COMPOSITION COMPRISING CCN5 AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING RETINAL DISEASES

16.5.2019
20.3.2024
  • :
    Olives Biotherapeutics Inc.
  • :
    219-1ho, 123, Cheomdangwagi-ro Buk-gu, Gwangju 61005, KR
  • :
    PARK, Woo Jin
  • :
    Gwangju 61005, KR
  • :
    YOON, Aeri
  • :
    Gwangju 61005, KR
  • :
    20180056499
  • :
    17.5.2018
  • :
    KR
  • :
    KR2019006011
  • :
    16.5.2019
  • :
    A61K 38/18, A61K 39/395, A61K 31/7105, A61K 31/7088, A61K 35/12, A61K 35/28, A61K 35/30, A61K 35/545, A61K 35/76, A61P 27/02, C07K 16/22, C12N 15/86